ibs glp 1 🔎Real-world data on GLP-1RA switching & discontinuation in pts 🔹1 in 3 pts switched agents 🔹IBS-M had the highest switching 🔹Liraglutide better tolerated than Semaglutide See graphical abstract for details ⬇️ # 後生元 Select Quantity:3 Bottles GIPR/GLP-1R dual agonist therapies

ibs glp 1 🔎Real-world data on GLP-1RA switching & discontinuation in pts 🔹1 in 3 pts switched agents 🔹IBS-M had the highest switching 🔹Liraglutide better tolerated than Semaglutide See graphical abstract for details ⬇️ # 後生元 Select Quantity:3 Bottles GIPR/GLP-1R dual agonist therapies

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application - PMC

Step 3: Targeted Blood Testing If you have spoken to your GP and still feel that you don't have the full picture, or if you want a detailed "snapshot" to monitor your progress while on a GLP-1, private testing can be a useful tool

後生元

Select Quantity:3 Bottles

A 2023 study published in The Lancet observed that patients taking semaglutide (Ozempic’s active ingredient) lost an average of 15% of their body weight compared to just 2% in those using a placebo​